Sagimet Biosciences (SGMT) Other financing activities (2022 - 2025)

Sagimet Biosciences' Other financing activities history runs 4 years deep, the most recent figure standing at -$300000.0 for Q4 2025.

• In Q4 2025, Other financing activities rose 67.78% year-over-year to -$300000.0; the TTM figure through Dec 2025 stood at $14000.0 (down 87.72% YoY), while the FY2024 annual figure was $114000.0, down 96.76% from the prior year.
• Other financing activities for Q4 2025 stood at -$300000.0, down from $300000.0 in the prior quarter.
• The five-year high for Other financing activities was $86.2 million in Q3 2023, with the low at -$82.6 million in Q4 2023.
• The 4-year median for Other financing activities is $77500.0 (2022), against an average of $368700.0.
• The sharpest annual moves came in 2023 and 2024: Other financing activities tumbled 150360.0% in 2023, then surged 98.87% in 2024.
• Sagimet Biosciences' Other financing activities stood at $55000.0 in 2022, then sank by 150360.0% to -$82.6 million in 2023, then soared by 98.87% to -$931000.0 in 2024, then jumped by 67.78% to -$300000.0 in 2025.
• Business Quant data shows SGMT's Other financing activities at -$300000.0 in Q4 2025, $300000.0 in Q3 2025, and -$931000.0 in Q4 2024.